US Looking At Joint Production Of Johnson And Johnson's In India
US Looking At Joint Production Of Johnson And Johnson's In India
Last month, the White House said that the US plans to share 60 million doses of AstraZeneca's vaccine globally as soon as they become available, and India expected a significant chunk of the total stockpile.
Updated: May 11, 2021 10:30 pm IST
The US is looking at joint production of Johnson and Johnson's vaccine in India, the envoy said.
New Delhi:
The US is looking at joint production of Johnson and Johnson's COVID-19 vaccine in India and ways to help manufacturers like the Serum Institute of India (SII) to boost production, Daniel B Smith, the Charge D'Affaires of the US embassy, said on Tuesday.